Topical mechlorethamine gel for mycosis fungoides launches in U. S

December 2013
Dermatology Times;Dec2013, Vol. 34 Issue 12, p21
Trade Publication
Product Review
The article offers brief information on the Valchor topical gel from Actelion.


Related Articles

  • Canada lags behind U.S. in mycosis fungoides tx. Otrompke, John // Dermatology Times;Feb2005, Vol. 26 Issue 2, p134 

    The article focuses on a variety of treatments for mycosis fungoides which are now available in the United States, but some of the newer medications are not yet available in Canada, making it even more important to catch the disease in its early stages. When it occurs in T-1 stage, patients...

  • Optimizing Care and Compliance for the Treatment of Mycosis Fungoides Cutaneous T-Cell Lymphoma With Mechlorethamine Gel. Chase, Allister Benjamin; Markel, Kristen; Tawa, Marianne C. // Clinical Journal of Oncology Nursing;Dec2015, Vol. 19 Issue 6, pE131 

    Background: Mycosis fungoides is the most common form of cutaneous T-cell lymphoma (MF-CTCL). Quality nursing care is necessary for effective diagnosis and treatment of patients with MF-CTCL. Early-stage MF-CTCL (stages Ia and Ib) is most often managed in both dermatology and multi-1...

  • XeraCalm A.D -- RESEARCH & DEVELOPMENT.  // Dermatology Times;Nov2014 Supplement, Vol. 35, p5 

    The article presents the views of dermatology professionals including Lawrence F. Eichenfield, Peter A. Lio, and Gary Goldenberg on research and development of new line of XeraCalm A.D Lipid-Replenishing products introduced by pharmaceutical and cosmetics executive Pierre Fabre. It discusses the...

  • CD 13 and TCR Clone: Markers of Early Mycosis Fungoides. Bernier, Claire; Nguyen, Jean-Michel; Quereux, Gaelic; Renault, Jean-jacques; Bureau, Brigne; Dreno, Brigitte // Acta Dermato-Venereologica;2007, Vol. 87 Issue 2, p155 

    Making a differential diagnosis between early mycosis fungoides (MF) and parapsoriasis is often difficult at the clinical and histological level. The aim of this study was to explore markers that could help in this process. A total of 88 patients were included in 2 categories: large plaque...

  • 2014 Annual Meeting of the Medical Dermatology Society.  // Journal of Investigative Dermatology;Jul2014, Vol. 134 Issue 7, p2058 

    The article presents abstracts on topics related to medical dermatology including the herpes zoster in hospitalized patients, early-onset mycosis fungoides among young African American women, and a retrospective review of the use of rituximab for treatment of pemphigus.

  • Pralatrexate.  // Reactions Weekly;2/20/2016, Vol. 1589 Issue 1, p173 

    An abstract of the article "Mexican patient with refractory mycosis fungoides successfully treated with pralatrexate at low doses: Case report" by J.R. Lopez and others is presented.

  • Single Asset Sends Ceptaris into Actelion's Arms. Powers, Marie // BioWorld Today;8/1/2013, Vol. 24 Issue 146, p1 

    The article reports on the 250 million U.S. dollars deal of Ceptaris Therapeutics Inc., with Actelion U.S. Holdings Co., a subsidiary of Swiss drugmaker Actelion Ltd. for its topical formulation Valchlor (mechlorethamine gel) for the treatment of early stage mycosis fungoides (MF). The deal is...

  • Patient's Advocate: When little more could be done, we did a lot. Stocker, Joyce; Liegey, Claudine; Cooley, Deborah; Nagle, Sigrid // RN;Aug90, Vol. 53 Issue 8, p25 

    Deals with the case of a patient diagnosed with mycosis fungoides, a cutaneous T-cell lymphoma. Experiences of nurses assigned to give care to the patient; Description of the condition of the patient; Reaction of nurses to the death of the patient.

  • Clinicopathological Manifestations of Ichthyosiform Mycosis Fungoides. Min Soo Jang; Dong Young Kang; Jong Bin Park; Sang Hwa Han; Kang Hoon Lee; Joon Hee Kim; Jae Won Ko; Kee Suck Suh // Acta Dermato-Venereologica;Jan2016, Vol. 96 Issue 1, p100 

    This article presents a study on the clinical and histopathological features of patients with ichthyosiform mycosis fungoides (MF). It discusses the materials and methods used in the study, the sole manifestation of MF in the patients, and treatments given to the patients. Histological findings...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics